Cardiac surveillance is mandatory in HER2+ metastatic breast cancer - discussion

19 June 2026 (16:50 - 17:00)
Organised by: Logo
Congress Presentation Part of: Rethinking cardiotoxicity monitoring – from tradition to evidence Cardiovascular Toxicity Monitoring CCO Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology